Literature DB >> 8059652

MR of neurocutaneous melanosis.

A J Barkovich1, I J Frieden, M L Williams.   

Abstract

PURPOSE: To describe the MR findings of neurocutaneous melanosis in the brain and correlate these with the known pathology and proposed embryologic basis of this disorder.
METHODS: The brain (seven patients) and spine (three patients) MR scans of seven patients with neurocutaneous melanosis were retrospectively reviewed. In two patients, findings were confirmed at surgery. The pattern of central nervous system involvement was also correlated with known pathologic studies regarding frequency and location of melanotic deposits.
RESULTS: Five patients had regions of T1 shortening in the cerebellum; three of these also had T2 shortening. Five patients had regions of T1 shortening in the anterior temporal lobes. Other areas of involvement included the pia mater over the cerebellum (two patients), pons (one patient), medulla (one patient), and left parietal lobe (one patient). Only two lesions showed enhancement, edema, or necrosis; both were proved malignant melanomas at biopsy. No pial enhancement was detected.
CONCLUSION: Neurocutaneous melanosis appears to involve the brain in specific locations that can be detected on MR imaging. Knowledge of these locations can aid in differentiating metastases, secondary to malignant degeneration of the large cutaneous nevi, from melanotic deposits that are a part of the disease. Identification of malignant degeneration of the melanotic deposits is difficult; at present, it depends on the identification of growth, edema, or necrosis of the deposits.

Entities:  

Mesh:

Year:  1994        PMID: 8059652      PMCID: PMC8332186     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

1.  Pediatric neuroradiology.

Authors:  W S Ball
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 2.  [New aspects of congenital melanocytic nevi].

Authors:  S Krengel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

Review 3.  A rare case of split pons with double encephalocoele, dermal sinus tract, and lipomeningomyelocele: a case report and review of literature.

Authors:  Shashank Ravindra Ramdurg; S Gubbi; A Odugoudar; V Kadeli
Journal:  Childs Nerv Syst       Date:  2013-06-30       Impact factor: 1.475

Review 4.  A giant congenital melanocytic nevus associated with neurocutaneous melanosis.

Authors:  S J Kim; J-H Kim; B Son; C Yoo
Journal:  Clin Neuroradiol       Date:  2013-10-31       Impact factor: 3.649

5.  Central nervous system imaging and congenital melanocytic naevi.

Authors:  V A Kinsler; S E Aylett; S C Coley; W K Chong; D J Atherton
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

6.  New insights into neurocutaneous melanosis.

Authors:  Ketsuda Jakchairoongruang; Yasmin Khakoo; Mark Beckwith; A James Barkovich
Journal:  Pediatr Radiol       Date:  2018-08-03

7.  Cerebellar development in the preterm neonate: effect of supratentorial brain injury.

Authors:  Emily W Y Tam; Donna M Ferriero; Duan Xu; Jeffrey I Berman; Daniel B Vigneron; A James Barkovich; Steven P Miller
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

Review 8.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

Review 9.  Neurocutaneous melanosis and the Dandy-Walker complex: an uncommon but not so insignificant association.

Authors:  Dominique Marnet; Matthieu Vinchon; Keyvan Mostofi; Benoit Catteau; Olivier Kerdraon; Patrick Dhellemmes
Journal:  Childs Nerv Syst       Date:  2009-08-27       Impact factor: 1.475

10.  Diffuse leptomeningeal hyperintensity on fluid-attenuated inversion recovery MR images in neurocutaneous melanosis.

Authors:  Masato Hayashi; Masayuki Maeda; Tomoaki Maji; Toshio Matsubara; Hirokazu Tsukahara; Kan Takeda
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.